SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-00-037193
Filing Date
2000-08-14
Accepted
2000-08-14 00:00:00
Documents
9
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a10-q.txt 10-Q 42575
2 EXHIBIT 3.1 ex-3_1.txt EX-3.1 1243
3 EXHIBIT 3.2 ex-3_2.txt EX-3.2 2444
4 EXHIBIT 3.3 ex-3_3.txt EX-3.3 29980
5 EXHIBIT 10.34 ex-10_34.txt EX-10.34 49926
6 EXHIBIT 10.35 ex-10_35.txt EX-10.35 6670
7 EXHIBIT 10.36 ex-10_36.txt EX-10.36 6571
8 EXHIBIT 10.37 ex-10_37.txt EX-10.37 23810
9 EX. 27 ex-27.txt EX-27 2078
  Complete submission text file 0000912057-00-037193.txt   167595
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 698238
SIC: 2836 Biological Products, (No Diagnostic Substances)